Home Tags Zydus Lifesciences

Tag: Zydus Lifesciences

Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.
Brands in Conversation

Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.

Passionate in Marketing -
0
Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity
Brands in Conversation

Zydus announces Final Approval from the USFDA for Indocyanine Green for Injection with 180-Days CGT exclusivity

Author -
0
Zydus Pinkathon Returns to Chennai After 7 Years, Set to Bring Thousands of Women Together for a Celebration of Health and Fitness
Brands in Conversation

Zydus Pinkathon Returns to Chennai After 7 Years, Set to Bring Thousands of Women Together for a Celebration of Health and Fitness

Author -
0
Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’
Brands in Conversation

Zydus marks Global Fatty Liver Day with the launch of new public awareness campaign – ‘Liver Ki Suno’

Author -
0
Zydus Therapeutics’ New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA
Brands in Conversation

Zydus Therapeutics’ New Drug Application (NDA) for Saroglitazar to treat Primary Biliary Cholangitis (PBC) granted Priority Review by the US FDA

Author -
0
Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
Brands in Conversation

Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India

Author -
0
Zydus and Lupin sign licensing agreement for co-marketing innovative Semaglutide Injection in India
Brands in Conversation

Zydus and Lupin sign licensing agreement for co-marketing innovative Semaglutide Injection in India

Author -
0
Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry, expanding patient access to GLP-1 therapy
Brands in Conversation

Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry, expanding patient access to GLP-1 therapy

Author -
0
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
Brands in Conversation

Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India

Author -
0
Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada
Brands in Conversation

Zydus and Formycon enter into an Exclusive Partnership for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab), in US and Canada

Author -
0
123Page 1 of 3